BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Given that BORT was also found to increase TSG expression that is silenced by BCR/ABL-promoted proteasome-dependent degradation [14], further investigations are necessary to clarify the role of BORT in controlling CML growth.